Advertisement
Australia markets closed
  • ALL ORDS

    7,943.60
    -31.20 (-0.39%)
     
  • AUD/USD

    0.6607
    -0.0010 (-0.16%)
     
  • ASX 200

    7,700.30
    -24.00 (-0.31%)
     
  • OIL

    78.53
    +0.08 (+0.10%)
     
  • GOLD

    2,331.50
    -17.60 (-0.75%)
     
  • Bitcoin AUD

    100,249.56
    -30.64 (-0.03%)
     
  • CMC Crypto 200

    1,386.94
    -1.22 (-0.09%)
     

Johnson Matthey Full Year 2024 Earnings: Misses Expectations

Johnson Matthey (LON:JMAT) Full Year 2024 Results

Key Financial Results

  • Revenue: UK£12.8b (down 14% from FY 2023).

  • Net income: UK£108.0m (down 59% from FY 2023).

  • Profit margin: 0.8% (down from 1.8% in FY 2023).

  • EPS: UK£0.59 (down from UK£1.44 in FY 2023).

revenue-and-expenses-breakdown
revenue-and-expenses-breakdown

All figures shown in the chart above are for the trailing 12 month (TTM) period

Johnson Matthey Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 5.3%. Earnings per share (EPS) also missed analyst estimates by 57%.

The primary driver behind last 12 months revenue was the PGM Services segment contributing a total revenue of UK£8.92b (69% of total revenue). Notably, cost of sales worth UK£11.9b amounted to 93% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to UK£410.0m (52% of total expenses). Explore how JMAT's revenue and expenses shape its earnings.

ADVERTISEMENT

Looking ahead, revenue is expected to fall by 60% p.a. on average during the next 3 years compared to a 10% decline forecast for the Chemicals industry in the United Kingdom.

Performance of the British Chemicals industry.

The company's shares are down 3.3% from a week ago.

Risk Analysis

It is worth noting though that we have found 3 warning signs for Johnson Matthey that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.